SHARON BIO-MEDICINE LTD. SHARE PRICE [LIVE]
| Open: | |
| High: | |
| Low: |
| MKT Cap: | |
| 52-wk High: | |
| 52-wk Low: |
| Prev close: | |
| P/E: | |
| Div yield: |
Fundamental analysis
What is not working for the company?
What is working for the company?
| Name | Jun 21 | Sep 19 |
|---|---|---|
| Promoters (Change:-32.53) | 0% | 32.53% |
| FIIs (Change:0.00) | 0% | 0% |
| Mutual Funds (Change:0.00) | 0% | 0% |
| Insurance Companies (Change:0.00) | 0% | 0% |
| Other DIIs (Change:0.01) | 0.02% | 0.01% |
| Non Institution (Change:32.52) | 99.98% | 67.46% |
Similar Stocks
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
If I had made LUMPSUM investment of ₹ 1,00,000
in SHARON BIO-MEDICINE LTD.
Months ago
My investment would be worth ₹ 1,41,900 with a Gain of 41.90 %
SHARONBIO News
Frequently Asked Questions
Can I buy SHARON BIO-MEDICINE LTD. (SHARONBIO) shares?
How do I buy SHARON BIO-MEDICINE LTD. (SHARONBIO) from Angel One?
- Direct investment: You can buy SHARON BIO-MEDICINE LTD. (SHARONBIO) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to SHARON BIO-MEDICINE LTD. (SHARONBIO) shares.
In which sector do SHARON BIO-MEDICINE LTD. (SHARONBIO) belong?
About SHARONBIO
Today's live share price for SHARON BIO-MEDICINE LTD. is NSE: N/A, BSE: N/A with a current market capitalization of .
Incorporated in 1989,Sharon Bio-Medicine Ltd is engaged in the pharmaceuticals/chemicals segment.The company had developed a number of products in active pharmaceutical ingredient (API), intermediates and formulations. During the fiscal year ended June 30, 2010, it had set up an active pharmaceutical ingredients plant in Taloja near Navi Mumbai.The company had installed capacity of 150,000 liters of reactors capacity of API and intermediates, and 2.5 billion tablets per shift per annum and one billion capsules per shift per annum. Its products include Trimetazidine Di Hydrochloride, Ketoconzole, Pentaprazole, Amlodipine Besylate, Atomoxetine Hcl, Carisoprodl, Closantel Base, Glimepiride, Ketoconazole, Nifedipibe, Racecadotril, Toldimfos, Telmisartan, Tamsulosin, Itraconazole, Mesalazine, Lansoprazole and Doxorubicin Inj.In January 2010,the Company started its toxicology laboratory and research and development unit at Taloja, Navi Mumbai.
Read more
